Literature DB >> 8336512

Potential for cancer related health services research using a linked Medicare-tumor registry database.

A L Potosky1, G F Riley, J D Lubitz, R M Mentnech, L G Kessler.   

Abstract

The National Cancer Institute and the Health Care Financing Administration share a strong research interest in cancer costs, access to cancer prevention and treatment services, and cancer patient outcomes. To develop a database for such research, the two agencies have undertaken a collaborative effort to link Medicare Program data with the Surveillance, Epidemiology, and End Results (SEER) Program database. The SEER Program is a system of 9 population-based tumor registries that collect standardized clinical information on cases diagnosed in separate, geographically defined areas covering approximately 10% of the US population. Using a deterministic matching algorithm, the records of 94% of SEER registry cases diagnosed at age 65 or older between 1973 to 1989, or more than 610,000 persons, were successfully linked with Medicare claims files. The resulting database, combining clinical characteristics with information on utilization and costs, will permit the investigation of the contribution of various patient and health care setting factors to treatment patterns, costs, and medical outcomes.

Entities:  

Mesh:

Year:  1993        PMID: 8336512

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  268 in total

1.  Analysis of identifier performance using a deterministic linkage algorithm.

Authors:  Shaun J Grannis; J Marc Overhage; Clement J McDonald
Journal:  Proc AMIA Symp       Date:  2002

2.  Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.

Authors:  Ying Chen; David R Lairson; Wenyaw Chan; Xianglin L Du
Journal:  Med Oncol       Date:  2017-08-03       Impact factor: 3.064

3.  Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.

Authors:  L Penberthy; S M Retchin; M K McDonald; D K McClish; C E Desch; G F Riley; T J Smith; B E Hillner; C J Newschaffer
Journal:  Health Care Manag Sci       Date:  1999-07

4.  Ability of Medicaid claims data to identify incident cases of breast cancer in the Ohio Medicaid population.

Authors:  Siran M Koroukian; Gregory S Cooper; Alfred A Rimm
Journal:  Health Serv Res       Date:  2003-06       Impact factor: 3.402

5.  Racial disparities in changing to a high-volume urologist among men with localized prostate cancer.

Authors:  Craig Evan Pollack; Justin E Bekelman; Andrew J Epstein; Kaijun Liao; Yu-Ning Wong; Katrina Armstrong
Journal:  Med Care       Date:  2011-11       Impact factor: 2.983

6.  Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.

Authors:  Beth M Beadle; Kai-Ping Liao; Sharon H Giordano; Adam S Garden; Katherine A Hutcheson; Stephen Y Lai; B Ashleigh Guadagnolo
Journal:  Cancer       Date:  2016-09-23       Impact factor: 6.860

7.  Effect of depression on diagnosis, treatment, and survival of older women with breast cancer.

Authors:  James S Goodwin; Dong D Zhang; Glenn V Ostir
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

8.  Blood transfusions and the subsequent risk of cancers in the United States elderly.

Authors:  Regina Riedl; Eric A Engels; Joan L Warren; Andrea Berghold; Winnie Ricker; Ruth M Pfeiffer
Journal:  Transfusion       Date:  2013-01-16       Impact factor: 3.157

9.  Assessing Cancer Treatment Information Using Medicare and Hospital Discharge Data among Women with Non-Hodgkin Lymphoma in a Los Angeles County Case-Control Study.

Authors:  Charlie Zhong; Petra Seibold; Chun R Chao; Wendy Cozen; Joo Y Song; Dennis Weisenburger; Leslie Bernstein; Sophia S Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-17       Impact factor: 4.254

10.  Colon Cancer Staging in Vulnerable Older Adults: Adherence to National Guidelines and Impact on Survival.

Authors:  T B Leal; T Holden; L Cavalcante; G O Allen; J R Schumacher; M A Smith; J M Weiss; H B Neuman; N K LoConte
Journal:  Ann Hematol Oncol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.